chevron_leftBack
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
301130
32.12CNY
1.6%
4.75 USD
As of 14 June 2026, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd has a market cap of $356.96M USD, ranking #17473 globally and #5418 in China.
It ranks #1581 in the Healthcare sector, and #569 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$356.96MUSD
2.42B CNY
Enterprise Value
$328.7MUSD
2.22B CNY
Revenue (TTM)
$34.66MUSD
234.84M CNY
EBITDA (TTM)
$7.74MUSD
52.4M CNY
Net Income (TTM)
$3.23MUSD
21.9M CNY
EBITDA Margin
22%
Profit Margin
9.3%
PE Ratio
110.4
PS Ratio
10.3
PB Ratio
2.6
EV/EBITDA
42.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jun Zhang
open_in_new
Employees
320
Founded
1990
Website
xidianyy.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.6% | 3.7% | 1.9% | 1.9% | 0.6% | 21% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301130
吉林省西点药业科技发展股份有限公司 Class A
ISIN: CNE1000058C4
Shares Out.:
Shares Outstanding:
75.495M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
32.12 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
15K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
14K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
8K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
5K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
5K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
4K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
213K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
153K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
101K%
|
97.4
|
|
SIX: RO
|
$321.52B
90K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
81K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
77K%
218.9B CHF
|
20.5
|
chevron_leftBack